-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research-2014.pdf
January 01, 2014 - Outcome Measure Framework Design Document
Effective Health Care Program
Number 43
Research Reports
Outcome Measure Framework Design
Document
Richard E. Gliklich, M.D.
Michelle B. Leavy, M.P.H.
Jannette Karl, M.B.A., P.M.P.
Daniel M. Campion, M.B.A.
Daniel Levy, M.S.
May 2014
Research from the Developing Evid…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
April 09, 2001 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001
April 09, 2001
Recommendations made by the USPSTF are independent of the …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_executive.pdf
April 01, 2012 - 1
Comparative Effectiveness Review
Number 62
Treatment for Depression After Unsatisfactory
Response to SSRIs
Executive Summary
Background
Depression is a complex mental illness
associated with disability and reduced
quality of life for the person with
depression, as well as substantial societal
burden. Major …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
April 18, 2012 - Evidence-based Practice Center Systematic Review Protocol
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Strategies To Improve Cardiovascular Risk Factors in People With Serious
Mental Illness: A Comparative Effectiveness Review
Amendment Date(s):
Amendment 1 – January 20, 20…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
June 01, 2012 - i
CER-Update # 5:
Comparative Effectiveness of Management Strategies
for Renal Artery Stenosis: 2007 Update
Original release date:
2007
Surveillance Report:
August, 2012
Key Findings:
• KQ1: 8 of 15 conclusions are probably out of date
• KQ2: 1 of 3 conclusions is possibly out of …
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Jones_29.pdf
February 23, 2008 - The AHRQ Hospital Survey on Patient Safety Culture: A Tool to Plan and Evaluate Patient Safety Programs
The AHRQ Hospital Survey on Patient Safety Culture:
A Tool to Plan and Evaluate Patient Safety Programs
Katherine J. Jones, PT, PhD; Anne Skinner, RHIA; Liyan Xu, MS; Junfeng Sun, PhD;
Keith Mueller, PhD
A…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
August 31, 2017 - Comparative Effectiveness Review Disposition of Comments Report: Anxiety in Children
Source: https://effectivehealthcare.ahrq.gov/topics/anxiety-children/research-2017/
Published Online: August 31, 2017
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Anxiety in Children
D…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - CER # 28:
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Children with Juvenile Idiopathic Arthritis (JIA)
Original release date: September 2011
Surveillance Report: February 2013
Key Findings:
- The conclusions for KQ1b (DMARDs vs conventionals
improve radiological progression), KQ2b (comparative
eff…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - CER # 28:
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Children with Juvenile Idiopathic Arthritis (JIA)
Original release date: September 2011
Surveillance Report: February 2013
Key Findings:
- The conclusions for KQ1b (DMARDs vs conventionals
improve radiological progression), KQ2b (comparative
eff…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - CER #55:
Drug Therapy for Rheumatoid Arthritis in Adults:
An Update
Original release date: April, 2012
Surveillance Report: May, 2013
Key Findings:
• For Key Question 1, conclusion on comparative effectiveness
of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
is probably out of date. Conclu…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - CER #55:
Drug Therapy for Rheumatoid Arthritis in Adults:
An Update
Original release date: April, 2012
Surveillance Report: May, 2013
Key Findings:
• For Key Question 1, conclusion on comparative effectiveness
of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
is probably out of date. Conclu…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
March 16, 2017 - First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2437
Published Online: March 16, 2017
Comparative Effectiveness Review Disposi…
-
effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
March 16, 2017 - First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2437
Published Online: March 16, 2017
Comparative Effectiveness Review Disposi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_surveillance.pdf
September 01, 2012 - Breast Abnormalities Update Surveillance Assessment_CER 47_Low
CER #47:
Noninvasive Diagnostic Tests for Breast
Abnormalities: Update of a 2006 Review
Original release date:
February, 2012
Surveillance Report:
January, 2013
Key Findings:
All of the key questions remain up-to-date.
Summary Deci…
-
hcup-us.ahrq.gov/reports/PDMPsAndOpioidHospitalizations.pdf
October 03, 2017 - PDMP and Opioid Hospitalizations
FEATURES OF PRESCRIPTION DRUG MONITORING PROGRAMS AND
THEIR RELATIONSHIP TO HOSPITAL UTILIZATION FOR
OPIOID-RELATED DIAGNOSES
2005-2013
Recommended Citation: Blanchard J, Raetzman SO, Washington R, Barrett ML, Stocks C,
Coffey R. Features of Prescription Drug Monitoring Pr…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/system/delivery-system-initiative/casalino/paper/casalino_idkeydsr.pdf
February 01, 2014 - for Delivery System Research
Even with criteria as specific as those I have just suggested—and I recognize
-
www.ahrq.gov/sites/default/files/publications/files/casalino_idkeydsr.pdf
February 01, 2014 - for Delivery System Research
Even with criteria as specific as those I have just suggested—and I recognize
-
hcup-us.ahrq.gov/reports/methods/2015_01.pdf
January 01, 2015 - In addition, it is important to recognize that some variables may have valid codes that
actually represent
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/fielding-cancer-53.pdf
July 14, 2017 - therapy, or cancer
surgery – anytime in the 6 months prior to being sampled.
1 The survey developers recognize
-
hcup-us.ahrq.gov/reports/methods/2005_02.pdf
January 01, 2005 - It is also important to recognize differences between ICD-9-CM procedures and CPT/HCPCS
procedures when